{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:21:42Z","timestamp":1782217302593,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T00:00:00Z","timestamp":1656115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["P1-0208"],"award-info":[{"award-number":["P1-0208"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.cbi.2022.110030","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T20:37:37Z","timestamp":1656103057000},"page":"110030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Effects of central nervous system drugs on androgen, estrogen \u03b1, glucocorticoid, and thyroid receptors"],"prefix":"10.1016","volume":"363","author":[{"given":"Ma\u0161a","family":"Kenda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taja","family":"Zore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0560-3762","authenticated-orcid":false,"given":"Marija","family":"Sollner Dolenc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2022.110030_bib1","series-title":"Global Assessment of the State-Of-The-Science of Endocrine Disruptors","author":"WHO","year":"2013"},{"key":"10.1016\/j.cbi.2022.110030_bib2","first-page":"715","article-title":"Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop","volume":"104","author":"Kavlock","year":"1996","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.cbi.2022.110030_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1210\/er.2009-0002","article-title":"Endocrine-disrupting chemicals: an Endocrine Society scientific statement","volume":"30","author":"Diamanti-Kandarakis","year":"2009","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cbi.2022.110030_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2015.00062","article-title":"Reporter cell lines for the characterization of the interactions between human nuclear receptors and endocrine disruptors","volume":"6","author":"Grimaldi","year":"2015","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cbi.2022.110030_bib5","doi-asserted-by":"crossref","first-page":"R73","DOI":"10.1530\/EJE-19-0154","article-title":"Drug-induced endocrinopathies and diabetes: a combo-endocrinology overview","volume":"181","author":"Diamanti-Kandarakis","year":"2019","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cbi.2022.110030_bib6","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3390\/jcm8091292","article-title":"Use of central nervous system (CNS) medicines in aged care homes: a systematic review and meta-analysis","volume":"8","author":"Hasan","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cbi.2022.110030_bib7","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the United States from 1999-2012","volume":"314","author":"Kantor","year":"2015","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.cbi.2022.110030_bib8","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s11356-018-3774-4","article-title":"Endocrine disruption as an adverse effect of non-endocrine targeting pharmaceuticals","volume":"26","author":"Sabir","year":"2019","journal-title":"Environ. Sci. Pollut. Res."},{"key":"10.1016\/j.cbi.2022.110030_bib9","first-page":"22","article-title":"SSRI antidepressant medications: adverse effects and tolerability","volume":"3","author":"Ferguson","year":"2001","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"10.1016\/j.cbi.2022.110030_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00004714-199902000-00013","article-title":"Effects of SSRIs on sexual function: a critical review","volume":"19","author":"Rosen","year":"1999","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.cbi.2022.110030_bib11","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3390\/molecules25071616","article-title":"Computational study of drugs targeting nuclear receptors","volume":"25","author":"Kenda","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2022.110030_bib12","series-title":"Stably Transfected Human Androgen Receptor Transcriptional Activation Assay for Detection of Androgenic Agonist and Antagonist Activity of Chemicals","year":"2015"},{"key":"10.1016\/j.cbi.2022.110030_bib13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tiv.2010.08.013","article-title":"Detection of thyroid hormone receptor disruptors by a novel stable in-vitro reporter-gene assay","volume":"25","author":"Freitas","year":"2011","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.cbi.2022.110030_bib14","series-title":"Test No. 455: Performance-Based Test Guideline for Stably Transfected Transactivation In-Vitro Assays to Detect Estrogen Receptor Agonists and Antagonists","year":"2016"},{"key":"10.1016\/j.cbi.2022.110030_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/toxsci\/66.1.69","article-title":"A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists","volume":"66","author":"Wilson","year":"2002","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2022.110030_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1289\/EHP6596","article-title":"Triclocarban, triclosan, bromochlorophene, chlorophene, and climbazole effects on nuclear receptors: an in-silico and in-vitro study","volume":"128","author":"Kenda","year":"2020","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.cbi.2022.110030_bib17","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.chembiol.2012.07.015","article-title":"Firefly luciferase in chemical biology: a compendium of inhibitors, mechanistic evaluation of chemotypes, and suggested use as a reporter","volume":"19","author":"Thorne","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.cbi.2022.110030_bib18","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.chembiol.2010.05.012","article-title":"Illuminating insights into firefly luciferase and other bioluminescent reporters used in chemical biology","volume":"17","author":"Thorne","year":"2010","journal-title":"Chem. Biol."},{"key":"10.1016\/j.cbi.2022.110030_bib19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.bbrc.2006.10.057","article-title":"Resveratrol inhibits firefly luciferase","volume":"351","author":"Bakhtiarova","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2022.110030_bib20","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/00007691-199612000-00006","article-title":"Relationships between carbamazepine-diol, carbamazepine-epoxide, and carbamazepine total and free steady-state concentrations in epileptic patients: the influence of age, sex, and co-medication","volume":"18","author":"Svinarov","year":"1996","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.cbi.2022.110030_bib21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.eplepsyres.2011.05.013","article-title":"Pharmacokinetics of eslicarbazepine acetate at steady-state in adults with partial-onset seizures","volume":"96","author":"Perucca","year":"2011","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.cbi.2022.110030_bib22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000069089","article-title":"Comparative single-dose pharmacokinetics of clonazepam following intravenous, intramuscular and oral administration to healthy volunteers","volume":"49","author":"Crevoisier","year":"2003","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.cbi.2022.110030_bib23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/10401239109147984","article-title":"Antidepressant response and plasma concentrations of fluoxetine","volume":"3","author":"Preskorn","year":"1991","journal-title":"Ann. Clin. Psychiatr."},{"key":"10.1016\/j.cbi.2022.110030_bib24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/cpt1976203329","article-title":"Clinical pharmacokinetics of lorazepam I. Absorption and disposition of oral 14C-lorazepam","volume":"20","author":"Greenblatt","year":"1976","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2022.110030_bib25","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/FTD.0000000000000457","article-title":"Serum concentrations of paliperidone after administration of the long-acting injectable formulation","volume":"39","author":"Helland","year":"2017","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.cbi.2022.110030_bib26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1055\/s-2005-864121","article-title":"Paroxetine serum concentrations in depressed patients and response to treatment","volume":"38","author":"Gilles","year":"2005","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.cbi.2022.110030_bib27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00406-004-0556-4","article-title":"Risperidone plasma levels, clinical response and side-effects","volume":"255","author":"Riedel","year":"2005","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.cbi.2022.110030_bib28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2165\/00003088-199700321-00004","article-title":"Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers","volume":"32","author":"Ronfeld","year":"1997","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.cbi.2022.110030_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.molcel.2013.08.037","article-title":"Distinct properties of cell-type-specific and shared transcription factor binding sites","volume":"52","author":"Gertz","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cbi.2022.110030_bib30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/toxsci\/kfu023","article-title":"AroER tri-screen is a biologically relevant assay for endocrine disrupting chemicals modulating the activity of aromatase and\/or the estrogen receptor","volume":"139","author":"Chen","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2022.110030_bib31","doi-asserted-by":"crossref","first-page":"420","DOI":"10.15386\/cjmed-868","article-title":"Fluoxetine modulates sex steroid levels in vitro","volume":"90","author":"Lupu","year":"2017","journal-title":"Med. Pharm. Rep."},{"key":"10.1016\/j.cbi.2022.110030_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tiv.2017.02.001","article-title":"The six most widely used selective serotonin reuptake inhibitors decrease androgens and increase estrogens in the H295R cell line","volume":"41","author":"Hansen","year":"2017","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.cbi.2022.110030_bib33","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.tiv.2015.07.005","article-title":"Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay","volume":"29","author":"Jacobsen","year":"2015","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.cbi.2022.110030_bib34","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.urology.2013.12.004","article-title":"Comparison of the effect of sertraline with behavioral therapy on semen parameters in men with primary premature ejaculation","volume":"83","author":"Akasheh","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.cbi.2022.110030_bib35","doi-asserted-by":"crossref","first-page":"672","DOI":"10.4103\/1008-682X.192637","article-title":"Sertraline-induced reproductive toxicity in male rats: evaluation of possible underlying mechanisms","volume":"19","author":"Atli","year":"2017","journal-title":"Asian J. Androl."},{"key":"10.1016\/j.cbi.2022.110030_bib36","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/toxsci\/kfy059","article-title":"Sertraline suppresses testis and adrenal steroid production and steroidogenic gene expression while increasing LH in plasma of male rats resulting in compensatory hypogonadism","volume":"163","author":"Munkboel","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2022.110030_bib37","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/0269881103174001","article-title":"Thyroid indices and response to fluoxetine and nortriptyline in major depression","volume":"17","author":"Gendall","year":"2003","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.cbi.2022.110030_bib38","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.pnpbp.2007.12.029","article-title":"Effects of various antidepressants on serum thyroid hormone levels in patients with major depressive disorder","volume":"32","author":"Eker","year":"2008","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.cbi.2022.110030_bib39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000026683","article-title":"Effect of paroxetine on thyroid hormone levels in severely depressed patients","volume":"42","author":"K\u00f6nig","year":"2000","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.cbi.2022.110030_bib40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000054954","article-title":"Effects of sertraline treatment on plasma cortisol, prolactin and thyroid hormones in female depressed patients","volume":"45","author":"\u0160agud","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.cbi.2022.110030_bib41","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1089\/thy.2008.0261","article-title":"Effects of selective serotonin reuptake inhibitors on thyroid function in depressed patients with primary hypothyroidism or normal thyroid function","volume":"19","author":"De Carvalho","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.cbi.2022.110030_bib42","first-page":"909","article-title":"Non-hormonal strategies for managing menopausal symptoms in cancer survivors: an update","volume":"13","author":"Biglia","year":"2019","journal-title":"E Cancer Med. Sci."},{"key":"10.1016\/j.cbi.2022.110030_bib43","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1056\/NEJMp1402080","article-title":"FDA approval of paroxetine for menopausal hot flushes","volume":"370","author":"Orleans","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2022.110030_bib44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12253-018-00569-x","article-title":"Hormone replacement therapy in cancer survivors \u2013 review of the literature","volume":"26","author":"Deli","year":"2020","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.cbi.2022.110030_bib45","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/bmj.c693","article-title":"Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population-based cohort study","volume":"340","author":"Kelly","year":"2010","journal-title":"Br. Med. J."},{"key":"10.1016\/j.cbi.2022.110030_bib46","article-title":"Revisiting the drug interaction between tamoxifen and SSRI antidepressants","volume":"354","author":"Juurlink","year":"2016","journal-title":"Br. Med. J."},{"key":"10.1016\/j.cbi.2022.110030_bib47","first-page":"1758","article-title":"Active tamoxifen metabolite plasma concentrations after co-administration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine","volume":"95","author":"Stearns","year":"2003","journal-title":"CancerSpectrum Knowl. Environ."},{"key":"10.1016\/j.cbi.2022.110030_bib48","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1111\/j.1528-1167.2009.02161.x","article-title":"Modulation of androgen and estrogen receptor expression by antiepileptic drugs and steroids in hippocampus of patients with temporal lobe epilepsy","volume":"50","author":"Killer","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.cbi.2022.110030_bib49","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1212\/WNL.57.3.440","article-title":"Early hormonal changes during valproate or carbamazepine treatment: a 3-month study","volume":"57","author":"R\u00e4tty\u00e4","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.cbi.2022.110030_bib50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.seizure.2015.02.022","article-title":"Interactions between antiepileptic drugs and hormones","volume":"28","author":"Svalheim","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.cbi.2022.110030_bib51","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1212\/01.WNL.0000098936.46730.64","article-title":"Effect of epilepsy and antiepileptic drugs on male reproductive health","volume":"62","author":"Isoj\u00e4rvi","year":"2004","journal-title":"Neurology"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722002356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722002356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:11:02Z","timestamp":1757859062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279722002356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":51,"alternative-id":["S0009279722002356"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2022.110030","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of central nervous system drugs on androgen, estrogen \u03b1, glucocorticoid, and thyroid receptors","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2022.110030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110030"}}